ABUSVSBGM• 28 Days (Normalized)
ABUS vs BGM (Arbutus Biopharma Corporation vs BGM Group Ltd.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABUS Performance $4.22
-17.58%
Arbutus Biopharma Corporation
Normalized Baseline0.00%
BGM Performance $10.75
+3987.45%
BGM Group Ltd.
Normalized Baseline0.00%
Alpha Spread Margin BGM LEADS
-4005.03 pts
BGM outperforming by 4005.03 percentage points
ABUSBGM
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABUS BGM
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | ABUS Price | ABUS Gain (%) | BGM Price | BGM Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $4.22 | -17.58% | $10.75 | +3987.45% | -4005.03% |
| Oct 08, 2026 | $4.18 | -18.36% | $9.96 | +3687.07% | -3705.43% |
| Oct 07, 2026 | $4.29 | -16.21% | $9.39 | +3470.34% | -3486.55% |
| Oct 06, 2026 | $4.48 | -12.50% | $9.65 | +3569.20% | -3581.70% |
| Oct 05, 2026 | $4.67 | -8.79% | $9.35 | +3455.13% | -3463.92% |
| Oct 02, 2026 | $4.45 | -13.09% | $9.34 | +3451.33% | -3464.42% |
| Oct 01, 2026 | $4.56 | -10.94% | $- | - | |
| Sep 30, 2026 | $4.78 | -6.64% | $- | - | |
| Sep 29, 2026 | $4.69 | -8.40% | $0.26 | -1.63% | -6.77% |
| Sep 28, 2026 | $4.86 | -5.08% | $0.24 | -7.22% | +2.14% |
| Sep 25, 2026 | $4.85 | -5.27% | $0.24 | -8.75% | +3.48% |
| Sep 24, 2026 | $4.88 | -4.69% | $0.25 | -5.32% | +0.63% |
| Sep 23, 2026 | $4.85 | -5.27% | $0.26 | -3.04% | -2.23% |
| Sep 22, 2026 | $5.01 | -2.15% | $0.26 | -2.85% | +0.70% |
| Sep 21, 2026 | $5.00 | -2.34% | $0.26 | -2.66% | +0.32% |
Page 1 of 2